These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5839867)

  • 1. Failure to detect 3,4-dimethoxyphenylethylamine and bufotenine in the urine from a case of periodic catatonia.
    Nishimura T; Gjessing LR
    Nature; 1965 May; 206(987):963-4. PubMed ID: 5839867
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES OF PERIODIC CATATONIA. II. THE URINARY EXCRETION OF PHENOLIC AMINES AND ACIDS WITH AND WITHOUT LOADS OF DIFFERENT DRUGS.
    GJESSING LR
    J Psychiatr Res; 1964 Oct; 2():149-62. PubMed ID: 14242373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical psychotherories. Where do we stand in 1971? 1. Monoamine theories].
    Giacobini E
    Lakartidningen; 1971 Dec; 68(49):5699-712. PubMed ID: 5137389
    [No Abstract]   [Full Text] [Related]  

  • 4. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-DIMETHOXYPHENYLETHYLAMINE AND OTHER AMINES IN THE URINE OF SCHIZOPHRENIC PATIENTS.
    TAKESADA M; KAKIMOTO Y; SANO I; KANEKO Z
    Nature; 1963 Jul; 199():203-4. PubMed ID: 14043215
    [No Abstract]   [Full Text] [Related]  

  • 6. 4-Methoxyphenylethylamine and 3,4-dimethoxyphenylethylamine in human urine.
    Sen NP; McGeer PL
    Biochem Biophys Res Commun; 1964; 14():227-32. PubMed ID: 5836511
    [No Abstract]   [Full Text] [Related]  

  • 7. FAILURE TO DETECT 3,4-DIMETHOXYPHENYLETHYLAMINE IN THE URINE OF SCHIZOPHRENICS.
    PERRY TL; HANSEN S; MACINTYRE L
    Nature; 1964 May; 202():519-20. PubMed ID: 14167856
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans.
    Friedhoff AJ; Hollister LE
    Biochem Pharmacol; 1966 Mar; 15(3):269-73. PubMed ID: 5911541
    [No Abstract]   [Full Text] [Related]  

  • 9. Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders.
    Takeda N; Ikeda R; Ohba K; Kondo M
    Neuroreport; 1995 Nov; 6(17):2378-80. PubMed ID: 8747157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation of monoamines to mental disorders].
    Rysánek K
    Act Nerv Super (Praha); 1970; 12(2):97-108. PubMed ID: 4913937
    [No Abstract]   [Full Text] [Related]  

  • 12. INVESTIGATION ON THE OCCURRENCE OF THE DOPAMINE METABOLITE 3,4-DIMETHOXYPHENYLETHYLAMINE IN THE URINE OF SCHIZOPHRENICS.
    Faurbye A; Pind K
    Acta Psychiatr Scand; 1964; 40(3):240-3. PubMed ID: 14295462
    [No Abstract]   [Full Text] [Related]  

  • 13. New ways with hallucinogens.
    Lancet; 1969 Mar; 1(7593):510. PubMed ID: 4179582
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships of phenethylamine hallucinogens.
    Nichols DE
    J Pharm Sci; 1981 Aug; 70(8):839-49. PubMed ID: 7031221
    [No Abstract]   [Full Text] [Related]  

  • 15. URINARY EXCRETION OF A 3-4, DIMETHOXYPHENYLETHYLAMINE-LIKE SUBSTANCE IN PARKINSON'S DISEASE.
    BARBEAU A; DEGROOT JA; JOLY JG; RAYMOND-TREMBLAY D; DONALDSON J
    Rev Can Biol; 1963; 22():469-72. PubMed ID: 14142201
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.
    Temporal KH; Scott KS; Mohr ALA; Logan BK
    J Anal Toxicol; 2017 Sep; 41(7):646-657. PubMed ID: 28472358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Br J Pharmacol; 1972 May; 45(1):165P-166P. PubMed ID: 5041482
    [No Abstract]   [Full Text] [Related]  

  • 18. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macromerine and normacromerine biosynthesis in Coryphantha macromeris var. runyonii.
    Keller WJ
    J Pharm Sci; 1979 Jan; 68(1):85-7. PubMed ID: 758472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of [alpha-14C] 3,4-dimethoxyphenethylamine among various organs of the rat.
    Schweitzer JW; Friedhoff AJ
    Biochim Biophys Acta; 1965 Nov; 111(1):326-8. PubMed ID: 5867328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.